🔎 Trials Near Me

Akèy › Dyabèt tip 1 › Indiana

Etid klinik pou Dyabèt tip 1 nan Indiana

14 etid pou Dyabèt tip 1 ap chèche patisipan nan sit nan Indiana.

Vil nan Indiana

Tèks ofisyèl etid la (Anglè)

Finding Immune Nascent Type 1 Diabetes

  • Indiana University School of Medicine, Indianapolis
Ap rekriteVolontè an sante akeyi
Laj 1 a 99 · Tout sèks · Mizajou Oct 2, 2026 · NCT07663136

App-Based Certified Diabetes Education Therapy (AB-CDE)

  • Indiana University, Indianapolis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07282639

Type 1 Diabetes Extension Study

  • Indiana University Riley Hospital for Children, Indianapolis
Ap rekriteEtid obsèvasyon
Laj 8 a 35 · Tout sèks · Mizajou Sep 18, 2026 · NCT02734277

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • Riley Hospital for Children- Indiana University, Indianapolis
Ap rekriteFaz 1/2
Laj 12 a 35 · Tout sèks · Mizajou Sep 11, 2026 · NCT06783309

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  • Indiana University-Riley Hospital for Children, Indianapolis
Ap rekriteFaz 2
Laj 8 a 45 · Tout sèks · Mizajou Sep 8, 2026 · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

  • Indiana University, Indianapolis
Ap rekriteFaz 1/2
Laj 9 a 20 · Tout sèks · Mizajou Sep 2, 2026 · NCT07061574

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

  • IUH - Riley Hospital for Children - Riley Outpatient Center - Pediatric Diabetes & Endocrinology, Indianapolis
Ap rekriteFaz 2
Laj 5 a 40 · Tout sèks · Mizajou Aug 24, 2026 · NCT07187531

The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action

  • Indiana University School of Medicine, Indianapolis
Ap rekriteFaz 2
Laj 11 a 18 · Tout sèks · Mizajou Aug 21, 2026 · NCT05414409

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

  • Indiana University, Indianapolis
Ap rekriteFaz 2
Laj 6 a 17 · Tout sèks · Mizajou Aug 13, 2026 · NCT07224321

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Indiana University, Indianapolis
Ap rekrite
Laj 14 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07579702

Denosumab for Type 1 Diabetes

  • Indiana University, Indianapolis
Ap rekriteFaz 1/2
Laj 18 a 50 · Tout sèks · Mizajou Jul 28, 2026 · NCT06524960

Registry for Stage 2 Type 1 Diabetes

  • Indiana University Health Riley Hospital for Children- Site Number : 8400004, Indianapolis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 13, 2026 · NCT06481904

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

  • Indiana University Health, Univeristy hospital, Indianapolis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 18, 2026 · NCT07287943

TrialNet Pathway to Prevention of T1D

  • Riley Hospital for Children, Indiana University, Indianapolis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 45 · Tout sèks · Mizajou Jul 1, 2025 · NCT00097292

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.